KMT2A and prostate neoplasm: To examine if prostate tumor-derived EVs could promote tumor establishment by inducing changes in the non-malignant prostate we injected MLL-EVs (n = 11), G-EVs (n = 11) or vehicle (PBS, n = 13) into the ventral prostate of naïve rats.